Share | RSS | Widgets | Home

[-]  16-04-18 19:23

Business Insider
Ketamine could become the first new depression drug in more than 30 years
Ketamine is emerging as a potential new drug for depression — the first of its kind in 35 years.
Johnson & Johnson is actively pursuing a nasal formulation of the drug. Researchers plan to present the results of an advanced clinical trial of the formula next month at the American Psychiatric Association meeting.
An early glimpse at some of the results suggests that the formula is safe and linked with sustained improvements in depressive symptoms over a year.

Ketamine, which has been...

Read the full article on Business Insider »
Facebook TwitterGoogle+

« Back to Feedjunkie.com